promomed
Ambene Bio
Ambene Bio
Ambene Bio
A bioactive chondroprotector with a unique composition; produced using modern bioextraction process.
LP-004183
Name Ambene Bio
Dosage form Solution for intramuscular and intraarticular administration
INN М09АХ
Active agent Formula, per ampule:
Bioactive extract from small-sized sea fish — 1.0 ml includes:
Active ingredient: concentrated extract from small-sized sea fish — 0.1 g/ml.
Excipients: phenol – up to 0.005 g/ml; water for injection up to 1.0 ml.
Specially developed for the treatment of chronic and progressive diseases of the joints and spine.

A combination of 4 components provides a diversified positive effect:

  • prevents degeneration and promotes regeneration of cartilage tissue;

  • inhibits the activity of the hyaluronidase enzyme, which destroys the components of the intra-articular fluid;

  • initiates the production of hyaluronic acid, thereby increasing the amount of intra-articular fluid and protecting the cartilage plate;

  • provides analgesic and anti-inflammatory effects, reducing the need for non-steroidal anti-inflammatory drugs.

10 injections are enough for a full course of therapy; the therapeutic effect is maintained up to 6 months. Many patients note a pronounced analgesic effect with onset as early as after the first injection¹.

How to use*:

Inject intramuscularly 2 ml once daily every other day – 10 injections in total.

Alternatively, 1 ml intramuscularly once daily for 20 days.

The product is natural for the body¹, it can be administered intra-articularly in 5 injections 2 ml each.

Notes:

Store at temperature from + 15 to + 25 °C. Do not use for the treatment of children and during pregnancy.

Indications:

  • pain in small and large joints;

  • spinal pain;

  • impaired flexion of the joints;

  • crepitus in the joints;

  • joint stiffness.

*Prescription product. Consult a doctor before use.

Komarov A.N. A comprehensive approach in the correction of pain syndrome and lumbar spine disorders in patients with chronic spondyloarthrosis in the exacerbation stage. Pharmateka. 2022;29(3): doi: 10.18565/pharmateca.2022.3.00-00